High-frequency ultrasound guidance for neurotoxin injections

Physical Medicine and Rehabilitation Clinics of North America

Volumn 21, Issue 3, 2010, Pages 607-630

  Alter, Katharine E ^a,b  

^a Mount Washington Pediatric Hospital   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Botulinum toxin; Dystonia; Pain; Spastic bladder; Spasticity; Ultrasound

Indexed keywords

ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; NEUROTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PURETOX; SNARE PROTEIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANUS FISSURE; ARTHRALGIA; ARTHRITIS; ASTHENIA; B SCAN; BLADDER NECK STENOSIS; BLADDER SPASM; BLEPHAROSPASM; BLURRED VISION; BREATHING DISORDER; BRUXISM; BULLOUS SKIN DISEASE; CERVICAL DYSTONIA; CLINICAL TRIAL; CLUBFOOT; COGNITIVE DEFECT; CONSTIPATION; CYSTALGIA; DIPLOPIA; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG SYNTHESIS; DYSHIDROSIS; DYSPAREUNIA; DYSPHAGIA; DYSPHONIA; ECHOGRAPHY; EPIDERMOLYSIS BULLOSA SIMPLEX; ESOPHAGUS ACHALASIA; FACIAL NERVE PARALYSIS; FOCAL DYSTONIA; FREY SYNDROME; HEADACHE; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; HYPERTROPHIC SCAR; IMAGE ANALYSIS; IMMUNOGENICITY; INTERMETHOD COMPARISON; INTERSTITIAL CYSTITIS; ISCHIALGIA; LOADING DRUG DOSE; LOW DRUG DOSE; MOTOR NEURON DISEASE; MUSCLE SPASM; MUSCLE WEAKNESS; MYOFASCIAL PAIN; NEEDLE; OBESITY; OFF LABEL DRUG USE; OROMANDIBULAR DYSTONIA; OSTEOARTHRITIS; OVERACTIVE BLADDER; PALATE DISEASE; PELVIS PAIN SYNDROME; POSTOPERATIVE PAIN; PREMATURE EJACULATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PSORIASIS; PTOSIS; RECOMMENDED DRUG DOSE; REVIEW; RHINITIS; SCHWARTZ JAMPEL SYNDROME; SEDATION; SHOULDER PAIN; SIDE EFFECT; STOMACH PARESIS; STRABISMUS; SUPPURATIVE HIDRADENITIS; TENNIS ELBOW; THORAX OUTLET SYNDROME; TRICHILEMMOMA; TRISMUS; ULTRASOUND TRANSDUCER; URGE INCONTINENCE; URINE INCONTINENCE; VAGINISM; XEROSTOMIA;

HUMANS; INJECTIONS; MUSCLE SPASTICITY; MUSCULOSKELETAL SYSTEM; NEUROTOXINS;

EID: 77955994917     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2010.05.001     Document Type: Review

References (68)

1. Elovic E.P., Esquenazi A., Alter K.E., et al. Chemodenervation in the management of spasticity and muscle overactivity. PMR 2009, 1(9):842-851.
2. Aoki K.R. Pharmacology and immunology of botulinum neurotoxins. Int Ophthalmol Clin 2005, 45(3):25-37.
3. Wenzel R.G. Pharmacology of botulinum neurotoxin A. Am J Heath-Sys Pharmac 2004, 61(Suppl 6):S5-10.
4. Botox [package insert]: Allergan, Inc. Irvine, CA.
5. Myobloc [package insert]: Solstice Neurosciences. Malvern, PA.
6. Dysport [prescribing information]. Brisbane, CA.
7. Binz T., Rummel A. Cell entry strategy of clostridial neurotoxins. J Niurochim 2009, 109:1584-1595.
8. Dolly O, Montel M. ICoN 2006. Proceedings of Applying Toxins Science to Clinical Practice.
9. Hallet M. One man's poison-clinical applications of botulinum toxin. NEJM 1999, 341(2):118.
10. Yan H., Frédéric D., Nancy J.G., et al. How botulinum and tetanus toxins block neurotransmitter release. Biochimie 2000, 82(5):427-446.
11. Pellizzari R., Rosetto O., Schiavo G., et al. Tetanus and botulinum neurotoxins: mechanisms of action and therapeutic uses [review]. Philos Trans R Soc Lond B Biol Sci 1999, 354(1381):259-268.
12. Aoki K.R., Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 2001, 8(Suppl 5):21-29.
13. Martin TF. Stages of regulate exocytosis. Trends Cell Biol 1997;7(7):271-6.
14. Meng J., Wang J., Lawrence G., et al. Synaptobrevin I mediates exocytoses of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J cell Sci 2007, 120:2864-2884.
15. Aoki K.R. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001, 248(Suppl 1):3-10.
16. FDA Alert. Information for Healthcare Professionals. August, 2009.
17. Scott A.B. Botulinum toxin injection in to extraocular muscles as an alternative to strabismus surgery. J Pediatr Opthalmol Strabismus 1980, 17:21-25.
18. Jankovic J., Brin M.F. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve 1997, 20(Suppl 6):S129-S145.
19. Jankovic J, Brin M. Botulinum toxin: historical perspective and potential new indications. Spasticity etiology, evaluation, management and the role of botulinum toxin. We move self study guide activity. 2002.
20. Schiano T.D., Fisher R.S., Parkman H.P., et al. Use of high resolution endoscopic ultrasonography to assess esophageal wall damage after balloon dilatation and botulinum toxin injection to treat achalasia. Gastrointest Endosc 1996, 44(2):151-157.
21. Schroeder A.S., Berweck S., Lee S., et al. Botulinum toxin treatment of children with cerebral palsy-a short review of different injection techniques. Neurotox Res 2006, 9(2-3):189-196.
22. Berweck S., Feldkamp A., Francke A., et al. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuroped 2002, 33:221-223.
23. Gracies JM, Elovic E, McGuire J, et al. Traditional pharmacologic treatments for spasticity part 1. Spasticity, etiology, evaluation, management and the role of botulinum toxin. We move self study guide activity. 2002.
24. Berweck S., Heinen F. Use of botulinum toxin in pediatric spasticity (cerebral palsy). Mov Dis 2004, 19(Suppl 8):S162-S167.
25. Berweck S., Schroeder A.S., Fietzek U.M., et al. Sonography-guided injection of botulinum toxin in children with cerebral palsy [letter to the editor]. Lancet 2004, 363(9404):249-250.
26. Chin TY, Nattrass GR, Slber P, et al. Accuracy of intramuscular injection of botulinum toxin A: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005, 25(3):286-291.
27. Yang E.J., Rha D.W., Yoo J.K., et al. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil 2009, 90:741-744.
28. Py A.G., Zein Addeen G., Perrier Y., et al. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Ann Phys Rehabil Med 2009, 52(3):215-223.
29. Kinnett D. Botulinum toxin A injections in children: technique and dosing issues. Am J Phys Med Rehabil 2004, 83(10 Suppl):S59-64.
30. Swering A, Berweck S, Fietzek UM, et al. Botulinum toxin B treatment in children with spastic movement disorders: a pilot study. Pediatric Neurology 2004, 31(2):109-113.
31. von Coelln R., Raible A., Gasser T., et al. Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord 2008, 23(6):889-892.
32. To E.W., Ahuja A.T., Ho W.S., et al. A prospective study of the effect o botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001, 54(3):197-200.
33. Lee I.H., Yoon Y.C., Sung D.H., et al. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. Am J Roentgenol 2009, 192:996-1001.
34. Nóbrega A.C., Rodrigues B., Melo A. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?. Clin Neurol Neurosurg 2009, 111:430-432.
35. Contarino M.F., Pompili M., Tittoto P., et al. Botulinum toxin B ultrasound guided injections for sialorrhea ALS and parkinsonism. Parkinsonism Relat Disord 2007, 13(5):299-303.
36. Meijer J.W., van Kuijk A.A., Geurts A.C., et al. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2008, 87(4):321-324.
37. Thevasagayam M.S., Gan K., Eksteen E. Control of salivary secretions in esophageal atresia with laryngeal cleft using botulinum toxin type A. Int J Pediatr Otorhinolaryngol 2008, 72(7):965-969.
38. Guntiana-Lichius O. Management of Frey's syndrome and hypersialorrhea with botulinum toxin. Facial Plast Surg Clin North Am 2003, 11:503-513.
39. Capaccio P., Cuccarini V., Benicchio V., et al. Treatment of iatrogenic submandibular sialocoele with botulinum toxin. Br J Oral Maxillofac Surg 2007, 45(5):415-417.
40. Ellies M., Laskawi R., Rohrbach-Volland S., et al. Up to date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J oral Maxillofac Surg 2003, 61:454-457.
41. Pena A., Cahill A.M., Gonzalez L., et al. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration. J Vasc Interv Radiol 2009, 20(3):368-373.
42. Mahowald M.L., Singh J.A., Dykstra D. Long term effects of botulinum toxin A for refractory joint pain. Nerotox Res 2006, 9:179-188.
43. Singh J.A., Mahowald M.L., Kushnaryov A., et al. Repeat injections of intra-articular botulinum toxin A for the treatment of chronic arthritis joint pain-a case series review. J Clin Rheumatol 2009, 15:35-38.
44. Sing J.S., Mahowald M.L., Noorbaloochi S. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Transl Res 2009, 153(5):205-216.
45. Boisaubert B. [Non surgical treatment of tennis elbow] Les traitements non chiurgicaux de la tendinopathie des epicondylitiens. Literature review. Ann Readapt Med Phys 2004, 47:346-355. [in French].
46. Housner J.A., Jacobson J.A., Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med 2009, 28(9):1187-1192.
47. Wong S.M., Hui A.C., Tong P.Y., et al. Treatment of lateral epicondylitis with botulinum toxin a randomized, double blind, placebo controlled trial. Ann Intern Med 2005, 143:793-797.
48. Knobloch K. Non-operative therapy in lateral epicondylitis. Fortschr Med 2009, 151(8):28-30.
49. Keizer S.B., Rutten H.P., Pilot P., et al. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin Orthoped Relat Res 2002, 401:125-131.
50. Oskarsson E., Piehl Aulin K., Gustafsson B.E., et al. Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment. Scand J Med Sci Sports 2009, 19(3):323-328.
51. Peng P.W., Tumber P.S. Ultrasound-guided interventional procedures for patients with chronic pelvic pain-a description of techniques and review of literature. Pain Phys 2008, 11(2):215-224.
52. Kirschner J.S., Foye P.M., Cole J.L. Piriformis syndrome, diagnosis and treatment. Muscle Nerve 2009, 40(1):10-18.
53. Yoon S.J., Ho J., Kang H.Y., et al. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome. Pharmacotherapy 2007, 27(5):657-665.
54. Finnoff JT, Hurdle MF, Smith J. Accuracy of ultrasound-guided versus fluoroscopically guided contrast-controlled piriformis injections: a cadaveric study. J Ultrasound Med 2008, 27(8):1157-1163.
55. Sanders R.J. Etiology and pathology. Hand Clin 2004, 20(1):23-26.
56. Jordan S.E., Ahn S.S., Gelabert H.A. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance. Pain Physician 2007, 10(4):541-546.
57. Danielson K., Odderson I.R. Botulinum toxin type A improves blood flow in vascular thoracic outlet syndrome. Am J Phys Med Rehabil 2008, 87(11):956-959.
58. Apostolidis A., Dasgupta P., Denys P., et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009, 55:100-119.
59. Sahai A., Khan M.S., Dasgupta P. Efficacy of botulinum toxin A for treating idiopathic detrusor overactivity: results for a single center, randomized, double blind placebo controlled trial. J Urol 2007, 177(6):2231-2236.
60. Flynn M.K., Amundsen C.L., Perevich M., et al. Outcome of a randomized double blind placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol 2009, 181(6):2608-2615.
61. Mazo E.B. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility]. Ter Arkh 2008, 80(10):49-52. [in Russian].
62. Chung Y.C., Chancellor M.B. The applications of botulinum toxin in the prostate. J Urol 2006, 176(6.1):2375-2382.
63. Maria G., Brisinda G., Civello I.M. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized placebo-controlled study+ comment. Urology 2003, 62(2):259-264.
64. Brisinda G., Cadeddu F., Vanella S., et al. Relief by botulinum to of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long term results. Urology 2009, 73(2):90-94.
65. Park D.S., Cho T.W., Lee Y.K., et al. Evaluation of the short term clinical effects and presumptive mechanism of botulinum toxin A as a treatment modality of benign prostatic hyperplasia. Yonsei Med J 2006, 47(5):706-714.
66. Christiansen J., Bruun E., Skjoldbye B., et al. Chronic idiopathic anal pain analysis of ultrasonography, pathology and treatment. Dis Colon Rectum 2001, 44(5):661-665.
67. Peng P.W., Tumber P.S. Ultrasound guided interventional procedures for patients with chronic pelvic pain-A description of techniques and review of the literature. Pain Physician 2008, 11(3):215-224.
68. Maria G., Brisinda G., Bentivoglio A.R., et al. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum 2000, 43(3):376-380.